Yiqin Luo

Discovery of <i>N</i>-((3<i>R</i>,4<i>R</i>)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1<i>H</i>-pyrazol-4-yl)amino)-9-methyl-9<i>H</i>-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR

Simon Planken, Douglas C. Behenna, Sajiv K. Nair et al. · Journal of Medicinal Chemistry · 2017 · 89 citations · Full text

Molecular Biology, Wild-type Egfr, Chemical Biology +21

Knockdown of METTL14 suppresses the malignant progression of non‑small cell lung cancer by reducing Twist expression

Fang Yang, Weiqi Yuan, Juan Li et al. · Oncology Letters · 2021 · 23 citations · Full text

Twist Expression, Transcription Factor Twist, Nsclc Tissues +17

Development of an ELISA for quantification of tumstatin in serum samples and tissue extracts of patients with lung carcinoma

Yiqin Luo, Li-JuanYao, Liang Zhao et al. · Clinica Chimica Acta · 2010 · 20 citations

Oncology, Allergy, Cancer Detection +12

High Platelet Levels Attenuate the Efficacy of Platinum-Based Treatment in Non-Small Cell Lung Cancer

Zhangfei Wang, Man Fang, Juan Li et al. · Cellular Physiology and Biochemistry · 2018 · 20 citations · Full text

Net Platelet Angiogenic Activity (NPAA) Correlates with Progression and Prognosis of Non-Small Cell Lung Cancer

Lijuan Yao, Dong Hang, Yiqin Luo et al. · PLoS ONE · 2014 · 15 citations · Full text